Bristol-Myers Squibb Earnings, Revenue Beat in Q2

Bristol-Myers Squibb Earnings, Revenue Beat in Q2
imageStock Markets29 minutes ago (Aug 06, 2020 07:00AM ET)

(C) Reuters. Bristol-Myers Squibb Earnings, Revenue Beat in Q2

Investing.com – Bristol-Myers Squibb (NYSE:BMY) reported on Thursday second quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Bristol-Myers Squibb announced earnings per share of $1.63 on revenue of $10.13B. Analysts polled by Investing.com anticipated EPS of $1.49 on revenue of $9.95B.

Bristol-Myers Squibb shares are down 7% from the beginning of the year, still down 12.66% from its 52 week high of $68.34 set on January 22. They are under-performing the S&P Global (NYSE:SPGI) 100 which is up 4.26% from the start of the year.

Bristol-Myers Squibb’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.

Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Bristol-Myers Squibb Earnings, Revenue Beat in Q2

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Leave a Reply

Your email address will not be published. Required fields are marked *